The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21.2 - Manufacture of pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
110 jobs Number of planned job losses
Announcement Date
26 August 2026
Employment effect (start)
27 August 2026
Foreseen end date
31 December 2028
Description
Innexis, a German pharmaceutical and life-science park operator, announced 110 full-time job reductions in Marburg, concluded by the end of 2028.
The internal restructuring aims to improve competitiveness after site closures and includes organisational changes, new technologies, process digitalisation and cross-site competence bundling.
The positions will be discontinued through non-replacement, voluntary departures and age-related exits.
The works council and employees were informed. A social plan is to be negotiated by end-2026 and implemented from early 2027.
Innexis employs about 650 people in Marburg and 850 across the group.
Citation
Eurofound (2026), Innexis, Internal restructuring in Germany, factsheet number 300937, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/300937.